Molecular Oncology

🌅Our July issue is online🌄 🔖Thematic issue on ‘Liquid Biopsy and Precision Oncology’ highlighting diverse approaches utilized in liquid biopsy research & clinical applications 🔓 buff.ly/3I7WAHM #LiquidBiopsies #ctDNA #CTC #ctDNA #CancerResearch #ClinicalOncology

A nucleotide-independent, pan-RAS-targeted DARPin elicits anti-tumor activity in a multimodal manner 🔦 buff.ly/EVTr8a8 @lab_santamaria #DARPin #DrugDevelopment #CancerTherapy

Targeting of PTP4A3 overexpression sensitises HGSOC cells towards chemotherapeutic drugs 👉 buff.ly/4OGCRch #HGSOC #Chemoresistance

Olaparib synergy screen reveals Exemestane induces replication stress in triple-negative breast cancer ➡️ buff.ly/vPDXjxq #TNBC #PARPi

🔍 We are looking for papers! 🤝 In conjunction with the recent @EACRnews conference on #ImmunoOncology we have an active call for papers! 📩 Submit your latest research in the field of #CancerImmunology #ImmunoOnc 🖊️ Whether it is a Research Article, Short Report or Method,…

⏳ There is still time to register and attend! ⚕️EACR Goodbye Flat Biology: ex vivo to in vivo models of cancer⚕️ 👇Register by Aug 26 💡 buff.ly/3XkCk1h #CancerModels #CancerModel #PreclinicalResearch #ModelOrganisms #TumourModels

Multi-omic characterization of consensus molecular subtype 1 (CMS1) colorectal cancer with dampened immune response improves precision medicine ➡️ buff.ly/yKCCKjU #CRCSM #PrecisionMedicine

Endoglin mediates the tumor- and metastasis-promoting traits of stromal myofibroblasts in human breast carcinomas 👉 buff.ly/2TVz9J7 #Endoglin #BCSM #Myofibroblasts

ℹ️ Don't miss our new Commentary Small modifier, big decision: switching to SUMO mode adds weight to cancer stemness in mammary tumors ➡️ buff.ly/ZscdSzr #Sumoylation #CancerStemness #BCSM

EMT-associated bias in the Parsortix® system observed with pancreatic cancer cell lines 🔦 buff.ly/39cTLtl 🖊️ @KathleenClaes1 @KrisGevaert_VIB #CTCs #LiquidBiopsy

We can't believe #FEBS2025 is over - we are still hyped! 🤯Excellent line-up of speakers, amazing quality of science and 🔥poster presentation standards! 🤝We support researchers with fair & rigorous peer review so reach out if you have questions about publishing with us…

🌟Are you joining the FEBS Press session? 💡Did you know Editors-in-Chief of the four FEBS Press journals are attending #FEBS2025? 🗣Talk to them about publishing in the not-for-profit FEBS Press journals or ask them about transformational agreements allowing you to publish for…

🏅 Congratulations to Nils Piernitzki from INM Leibniz Institute for New Materials for winning the daily poster prize from Molecular Oncology with her poster "Artificial tumour immune microenvironments for hybrid 3D cancer cultures" #FEBS2025 #FEBSCongress2025

🏅 Congratulations to Patryk Lorenc for winning the daily poster prize from Molecular Oncology with his poster "Double functionalised silk nanoparticles for the delivery of oligotherapeutics to VEGFR overexpressing tumour microenvironment cells"👏 #FEBS2025 #FEBSCongress2025

On Day 2 of the #FEBSCongress2025, we were happy to attend the talks from two of our Section Editors on: Cancer metabolism and anti-tumour immunity by Prof. @jer_06200 Did you know that low-protein diet can modulate cancer progression? The epigenetic code in autophagy and…

🏅 Congratulations to Annamaria Antona for winning the daily poster prize from Molecular Oncology with her poster "Adipose derived mesenchymal stem cells drive endometrial progression by establishing protumourigenic metabolic interactions with cancer cells" #FEBS2025…

🚄En route to #FEBS2025 ✅If you're joining us in Istanbul, make sure you check out the FEBS booth to get the latest information on travel grants and fellowships! 📝You can also talk to the Molecular Oncology team for your next paper or ask any questions about publishing…

🧪 Targeting carbonic anhydrase IX/XII prevents the anti-ferroptotic effect of stromal lactic acid in prostate carcinoma 👉 buff.ly/3vJliyq 🥼 @ElisaPardella @UNI_FIRENZE #Ferroptosis #LacticAcid #ProstateCancer #CAFs #CarbonicAnhydrase

Chimeric diphtheria toxin–CCL8 cytotoxic peptide for breast cancer management ➡️ buff.ly/ATJrUCp #Chemokine #CCR5 #BCSM 🖊️ @hkiaris1 @Bernardneuro

😔 Feeling the #EACR2025 Congress blues? 📣 Abstracts submitted to the ‘EACR 2025 Congress: Innovative Cancer Science’ can be browsed online! 🔎 Find them here 👉 buff.ly/sV3HCkW 🔓 #EACR2025 #EACR #CancerResearch #CancerBiology #CancerResearchers